Literature DB >> 32976363

Barriers, Facilitators, and Cost of Integrating HIV-Related Activities Into Sexually Transmitted Disease Partner Services in Jackson, Mississippi.

Peder Digre1, Tigran Avoundjian2, Kendra Johnson3, David Peyton3, Christie Lewis3, Ruanne V Barnabas, Matthew R Golden, Christine M Khosropour2.   

Abstract

BACKGROUND: Many US health departments now integrate HIV-related outcomes (e.g., relinkage to HIV care and preexposure prophylaxis [PrEP]) into sexually transmitted disease (STD) partner services (PS) programs. We sought to determine the barriers, facilitators, and cost of integrating these activities into PS.
METHODS: From 2016 to 2018, the Mississippi State Department of Health integrated 3 new activities into STD PS: HIV testing for partners of HIV-negative men who have sex with men with gonorrhea/chlamydia, relinkage to HIV care for STD PS recipients previously diagnosed with HIV, and PrEP referrals. We conducted direct observations and interviews with disease intervention specialists (DIS) in Jackson to assess barriers and facilitators to implementing these activities. We completed time and motion studies with 8 DIS and case tracking forms for 90 unique cases to estimate the incremental staff time and associated personnel cost of added services compared with a standard PS case.
RESULTS: Disease intervention specialists were optimistic about integrating HIV-related activities but noted disparate data systems, nonsystematic documentation, and lack of training as barriers. The mean time for a standard STD PS case without HIV-related activities was 195 minutes (cost, $77.69/case). The cost to conduct PS for HIV-negative men who have sex with men with gonorrhea/chlamydia was 36% higher than a standard case. Integrating relinkage to care and PrEP referrals resulted in a 44% and 20% increase in cost, respectively.
CONCLUSIONS: Integrating HIV care relinkage and PrEP referrals into STD partner services was generally acceptable by DIS and added marginal cost per case. Coupling these cost metrics with an assessment of the effectiveness of these activities can inform prioritization of partner services activities.
Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 32976363      PMCID: PMC9033159          DOI: 10.1097/OLQ.0000000000001296

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  13 in total

1.  The Number of Interviews Needed to Yield New Syphilis and Human Immunodeficiency Virus Cases Among Partners of People Diagnosed With Syphilis, North Carolina, 2015.

Authors:  Erika Samoff; Anna B Cope; Jason Maxwell; Francina Thomas; Victoria L Mobley
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

3.  Cost Analysis and Performance Assessment of Partner Services for Human Immunodeficiency Virus and Sexually Transmitted Diseases, New York State, 2014.

Authors:  Britney L Johnson; James Tesoriero; Wenhui Feng; Feng Qian; Erika G Martin
Journal:  Health Serv Res       Date:  2017-08-11       Impact factor: 3.402

4.  Sexually Transmitted Disease Partner Services Costs, Other Resources, and Strategies Across Jurisdictions to Address Unique Epidemic Characteristics and Increased Incidence.

Authors:  Rachel A Silverman; David A Katz; Carol Levin; Teal R Bell; Dawn Spellman; Lisa St John; Evelyn Manley Rodriguez; Matthew R Golden; Ruanne V Barnabas
Journal:  Sex Transm Dis       Date:  2019-08       Impact factor: 2.830

5.  Assessing Sexually Transmitted Disease Partner Services in State and Local Health Departments.

Authors:  Kendra M Cuffe; Jami S Leichliter; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2018-06       Impact factor: 2.830

Review 6.  Modernizing Field Services for Human Immunodeficiency Virus and Sexually Transmitted Infections in the United States.

Authors:  Matthew R Golden; David A Katz; Julia C Dombrowski
Journal:  Sex Transm Dis       Date:  2017-10       Impact factor: 2.830

Review 7.  Partner Services in Sexually Transmitted Disease Prevention Programs: A Review.

Authors:  Matthew Hogben; Dayne Collins; Brooke Hoots; Kevin OʼConnor
Journal:  Sex Transm Dis       Date:  2016-02       Impact factor: 2.830

8.  Rates of Prevalent HIV Infection, Prevalent Diagnoses, and New Diagnoses Among Men Who Have Sex With Men in US States, Metropolitan Statistical Areas, and Counties, 2012-2013.

Authors:  Eli Samuel Rosenberg; Jeremy Alexander Grey; Travis Howard Sanchez; Patrick Sean Sullivan
Journal:  JMIR Public Health Surveill       Date:  2016-05-17

9.  State-Specific Rates of Primary and Secondary Syphilis Among Men Who Have Sex with Men - United States, 2015.

Authors:  Alex de Voux; Sarah Kidd; Jeremy A Grey; Eli S Rosenberg; Thomas L Gift; Hillard Weinstock; Kyle T Bernstein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-07       Impact factor: 17.586

10.  Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration.

Authors:  Randall C Gale; Justina Wu; Taryn Erhardt; Mark Bounthavong; Caitlin M Reardon; Laura J Damschroder; Amanda M Midboe
Journal:  Implement Sci       Date:  2019-02-01       Impact factor: 7.327

View more
  2 in total

1.  A Demedicalized Model to Provide PrEP in a Sexual Health Clinic.

Authors:  Meena S Ramchandani; Anna Berzkalns; Chase A Cannon; Julia C Dombrowski; Negusse Ocbamichael; Christine M Khosropour; Lindley A Barbee; Matthew R Golden
Journal:  J Acquir Immune Defic Syndr       Date:  2022-08-15       Impact factor: 3.771

2.  Integrating HIV services and other health services: A systematic review and meta-analysis.

Authors:  Caroline A Bulstra; Jan A C Hontelez; Moritz Otto; Anna Stepanova; Erik Lamontagne; Anna Yakusik; Wafaa M El-Sadr; Tsitsi Apollo; Miriam Rabkin; Rifat Atun; Till Bärnighausen
Journal:  PLoS Med       Date:  2021-11-09       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.